120 related articles for article (PubMed ID: 29667177)
21. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
22. Intrauterine valproate exposure is associated with alterations in hippocampal cell numbers and folate metabolism in a rat model of valproate teratogenicity.
Semmler A; Frisch C; Bleul C; Smith D; Bigler L; Prost JC; Blom H; Linnebank M
Seizure; 2017 Mar; 46():7-12. PubMed ID: 28212902
[TBL] [Abstract][Full Text] [Related]
23. Effect of valproic acid on fetal and maternal organs in the mouse: a morphological study.
Emmanouil-Nikoloussi EN; Foroglou NG; Kerameos-Foroglou CH; Thliveris JA
Morphologie; 2004 Apr; 88(280):41-5. PubMed ID: 15208813
[TBL] [Abstract][Full Text] [Related]
24. Polycomb homologs are involved in teratogenicity of valproic acid in mice.
Okada A; Aoki Y; Kushima K; Kurihara H; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):870-9. PubMed ID: 15523661
[TBL] [Abstract][Full Text] [Related]
25. Investigating the effects of valproic acid on placental epigenetic modifications and development in the CD-1 mouse model.
Jackson BL; Shafique S; Natale BV; Natale DRC; Winn LM
Reprod Toxicol; 2024 Mar; 124():108551. PubMed ID: 38280688
[TBL] [Abstract][Full Text] [Related]
26. [Effect of anti-epileptic drugs on human placenta and the fetus].
Semczuk-Sikora A; Semczuk M
Ginekol Pol; 2004 Feb; 75(2):166-9. PubMed ID: 15108592
[TBL] [Abstract][Full Text] [Related]
27. The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and α-tocopherol.
Chen Y; Lin PX; Hsieh CL; Peng CC; Peng RY
PLoS One; 2014; 9(12):e116534. PubMed ID: 25551574
[TBL] [Abstract][Full Text] [Related]
28. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
29. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
Hsieh CL; Wang HE; Tsai WJ; Peng CC; Peng RY
Toxicology; 2012 Jan; 291(1-3):32-42. PubMed ID: 22051200
[TBL] [Abstract][Full Text] [Related]
30. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
31. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
[TBL] [Abstract][Full Text] [Related]
32. The protective effect of polyunsaturated fatty acid intake during pregnancy against embryotoxicity of sodium valproate in mice.
Li K; Li J; Gu J; Guo X; Gao T; Li D
Food Funct; 2018 May; 9(5):2634-2643. PubMed ID: 29561026
[TBL] [Abstract][Full Text] [Related]
33. Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice.
Downing C; Biers J; Larson C; Kimball A; Wright H; Ishii T; Gilliam D; Johnson T
Toxicol Sci; 2010 Aug; 116(2):632-9. PubMed ID: 20457659
[TBL] [Abstract][Full Text] [Related]
34. Folate Transporters in Placentas from Preterm Newborns and Their Relation to Cord Blood Folate and Vitamin B12 Levels.
Castaño E; Caviedes L; Hirsch S; Llanos M; Iñiguez G; Ronco AM
PLoS One; 2017; 12(1):e0170389. PubMed ID: 28103309
[TBL] [Abstract][Full Text] [Related]
35. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
[TBL] [Abstract][Full Text] [Related]
36. Effects of antiseizure medications on placental cells: Focus on heterodimeric placental carriers.
Tetro N; Hamed R; Berman E; Eyal S
Epilepsy Res; 2021 Aug; 174():106664. PubMed ID: 34022522
[TBL] [Abstract][Full Text] [Related]
37. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
Hishida R; Nau H
Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
[TBL] [Abstract][Full Text] [Related]
38. Adverse effect of valproic acid on an in vitro gastrulation model entails activation of retinoic acid signaling.
Li AS; Marikawa Y
Reprod Toxicol; 2016 Dec; 66():68-83. PubMed ID: 27693483
[TBL] [Abstract][Full Text] [Related]
39. Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin--developmental effects of valproic acid.
Wiltse J
Crit Rev Toxicol; 2005; 35(8-9):727-38. PubMed ID: 16417040
[TBL] [Abstract][Full Text] [Related]
40. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
